MBB Public Markets’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-78,598
Closed -$1.28M 689
2024
Q2
$1.28M Buy
78,598
+63,276
+413% +$975K 0.03% 458
2024
Q1
$216K Buy
+15,322
New +$193K 0.01% 270

Other funds holding TEVA

MBB Public Markets's TEVA Position: Q3 2024 in Review

MBB Public Markets sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q3 2024, closing a stake of 78,598 shares — an estimated $1.28M sold.

MBB Public Markets first reported a position in TEVA in Q1 2024 and held it in 2 quarters. The position peaked at $1.28M in Q2 2024. 543 funds tracked by Wall St. Rank hold TEVA as of Q3 2024.

  • MBB Public Markets reported no remaining Teva Pharmaceutical Industries Limited position as of Q3 2024 after selling out during the quarter.
  • MBB Public Markets sold 78,598 Teva Pharmaceutical Industries Limited shares in Q3 2024, an estimated $1.28M.
  • MBB Public Markets first reported a position in Teva Pharmaceutical Industries Limited in Q1 2024 and held it in 2 quarters.
  • MBB Public Markets's Teva Pharmaceutical Industries Limited position peaked at $1.28M in Q2 2024.
  • 543 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2024.

Based on MBB Public Markets's 13F filing for Q3 2024, filed 14 Nov 2024.